On November 10, 2025, a research team from the Massachusetts Institute of Technology in the United States developed a novel nano-delivery particle that significantly enhances the efficacy of mRNA vaccines. This technology improves delivery efficiency by optimizing particle structure, potentially reducing the amount of active ingredient required per vaccine dose, thereby lowering production costs. The related findings were published in the journal Nature Nanotechnology.
